Home

             UMLS 2025

8/10

C5702237

ICD-10 (International Classification of Diseases, 10th Revision)
ICD-10 is split into two systems for use in the U.S.:
CPT (Current Procedural Terminology)
HCPCS (Healthcare Common Procedure Coding System)
HCPT (HCPCS Version of Current Procedural Terminology).HCPT is another name for the HCPCS Level I set.


Enter one or more words or parts of words
   

Dict Code CUI Term usa.gov
 CPT 0342U  C5702237 Oncology (pancreatic cancer), multiplex immunoassay of C5, C4, cystatin C, factor B, osteoprotegerin (OPG), gelsolin, IGFBP3, CA125 and multiplex electrochemiluminescent immunoassay (ECLIA) for CA19-9, serum, diagnostic algorithm reported qualitatively as positive, negative, or borderline preferred
 CPT 0342U  C5702237 ONC PNCRTC CA MULT IA ECLIA SRM ALG no pref
 CPT 0342U  C5702237 ONC PNCRTC CA MULT IA ECLIA no pref
 CPT 0342U  C5702237 Multiplex immunoassay of C5, C4, cystatin C, factor B, osteoprotegerin (OPG), gelsolin, IGFBP3, CA125 and multiplex electrochemiluminescent immunoassay (ECLIA) for CA19-9 in serum specimen, diagnostic algorithm reported qualitatively as positive, negative, or borderline for pancreatic cancer no pref
 HCPT 0342U  C5702237 Onc pncrtc ca mult ia eclia no pref
C5702237








Read more: https://www.nlm.nih.gov/research/umls/sourcereleasedocs/


Web development by Gayane Margaryan